Treatment Development of Triheptanoin (G1D)

NCT03041363 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Epilepsy
GLUT1DS1
Glut1 Deficiency Syndrome 1, Autosomal Recessive
Glucose Metabolism Disorders
Glucose Transport Defect
Glucose Transporter Type 1 Deficiency Syndrome
Glucose Transporter Protein Type 1 Deficiency Syndrome

Interventions

DRUG: Triheptanoin

Sponsor

Juan Pascual

Collaborators

[object Object]